Clinicopathological and molecular characterization of colorectal micropapillary carcinoma

Modern Pathology

Volumn 24, Issue 5, 2011, Pages 729-738

  Verdú, Montse ^a,b   Román, Ruth ^a   Calvo, Miquel ^c   Rodón, Natlia ^a   García, Beatriz ^a   González, Marta ^a   Vidal, August ^a,b   Puig, Xavier ^a,b,d  

^a BIOPAT   (Spain)

^b Histopat Laboratoris   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d NONE   (Spain)

Author keywords

clinicopathological characterization; colorectal cancer; immunohistochemistry; micropapillary carcinoma; molecular characterization; MUC1

Indexed keywords

B RAF KINASE; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 5; FORMALDEHYDE; MEMBRANE PROTEIN; MUCIN 1; PARAFFIN; PROTEIN KRT20; PROTEIN KRT7; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6; PROTEIN P53; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER INVASION; CHROMOSOME 17P; CHROMOSOME 18Q; CLINICAL FEATURE; COLORECTAL CARCINOMA; COLORECTAL MICROPAPILLARY CARCINOMA; DNA EXTRACTION; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 79955572697     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2011.1     Document Type: Article

References (33)

1. Siriangkul S, Tavasoli FA. Invasive micropapillary carcinoma of the breast. Mod Pathol 1993;6:660-662.
2. Amin MB, Ro YJ, el-Sharkawy T, et al. Micropapillary variant of transitional cell carcinoma of the urinary bladder. Histologic pattern resembling ovarian papillary carcinoma. Am J Surg Pathol 1994;18:1224-1232. (Pubitemid 24362435)
3. Paterakos M, Watkin WG, Edgerton SM, et al. Invasive micropapillary carcinoma of the breast: a prognostic study. Hum Pathol 1999;30:1459-1463. (Pubitemid 30032922)
4. Nassar H, Wallis T, Andea A, et al. Clinicopathologic analysis of invasive micropapillary differentiation in breast carcinoma. Mod Pathol 2001;14:836-841. (Pubitemid 32889240)
5. Amin MB, Tamboli P, Merchant SH, et al. Micropapil-lary component in lung adenocarcinoma: a distinctive histologic feature with possible prognostic significance. Am J Surg Pathol 2002;26:258-364.
6. Zekioglu O, Erhan Y, Ciris M, et al. Invasive micropapillary carcinoma of the breast: high incidence of lymph node metastasis with extranodal extension and its immunohistochemical profile compared with invasive ductal carcinoma. Histopathology 2002;44:18-23. (Pubitemid 38174865)
7. Nassar H. Carcinomas with micropapillary morphology: clinical significance and current concepts. Adv Anat Pathol 2004;11:297-303. Review.
8. Sakamoto K, Watanabe M, De la Cruz C, et al. Primary invasive micropapillary carcinoma of the colon. Histopathology 2005;47:479-484. (Pubitemid 41626725)
9. Kim MJ, Hong SM, Jang SJ, et al. Invasive colorectal micropapillary carcinoma: an aggressive variant of adenocarcinoma. Hum Pathol 2006;37:809-815. (Pubitemid 43902958)
10. Haupt B, Ro JY, Schwartz MR, et al. Colorectal adenocarcinoma with micropapillary pattern and its association with lymph node metastasis. Mod Pathol 2007;20:729-733. (Pubitemid 46933443)
11. Wen P, Xu Y, Frankel WL, et al. Invasive micropapil-lary carcinoma of the sigmoid colon: distinct morphology and aggressive behavior. Int J Clin Exp Pathol 2008;1:457-460.
12. Kuroda N, Oonishi K, Ohara M, et al. Invasive micropapillary carcinoma of the colon: an immuno-histochemical study. Med Mol Morphol 2007;40: 226-230. (Pubitemid 350277681)
13. Xu F, Xu J, Lou Z, et al. Micropapillary component in colorectal carcinoma is associated with lymph node metastases in T1 and T2 stages and decreased survival time in TNM stages I and II. Am J Surg Pathol 2009;33:1287-1292.
14. Nassar H, Pansare V, Zhang H, et al. Pathogenesis of invasive micropapillary carcinoma: role of MUC1 glycoprotein. Mod Pathol 2004;17:1045-1050. (Pubitemid 39128230)
15. Li YS, Kaneko M, Sakamoto DG, et al. The reversed apical pattern of MUC1 expression is characteristics of invasive micropapillary carcinoma of the breast. Breast Cancer 2006;13:58-63.
16. Hamilton SR, Aaltonen LA, eds. World Health Organization Classification of Tumors. Pathology and Genetics of Tumours of the Digestive System. IARC Press: Lyon, 2000;103-143.
17. Sobin LH, Wittekind Ch, eds. TNM Classification of Malignant Tumors. 6th edn. Wilsey-Liss: New York 2002.
18. Compton CC. Colorectal carcinoma: diagnostic, prognostic, and molecular features. Mod Pathol 2003;16: 376-388. (Pubitemid 36443987)
19. Carethers JM, Smith EJ, Behling CA, et al. Use of 5-fluorouracil and survival in patients with micro-satellite-unstable colorectal cancer. Gastroenterology 2004;126:394-401. (Pubitemid 38182296)
20. Valentini AM, Armentano R, Pirrelli M, et al. Immunohistochemical mismatch repair proteins expression in colorectal cancer. Appl Immunohistochem Mol Morphol 2006;14:42-45.
21. Shibata DK, Arnheim N, Martin WJ. Detection of human papillomavirus in paraffin-embedded tissue using the polymerase chain reaction. J Exp Med 1988;167:225-230. (Pubitemid 18093706)
22. Bauer HM, Ting Y, Greer CE, et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 1991;265:472-477.
23. Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute Workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58:5248-5257. (Pubitemid 28521189)
24. Jen J, Kim H, Piantadosi S, et al. Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med 1994;331:213-221. (Pubitemid 24226678)
25. Jones MH, Nakamura Y. Detection of loss of hetero-zygosity at the human TP53 locus using a dinucleotide repeat polymorphism. Genes Chromosomes Cancer 1992;5:89-90.
26. R Development Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing: Vienna, Austria, 2006. ISBN 3-900051-07-0, URLhttp://www.R-project.org.
27. Hothorn T, Hornik K. Exact RankTests: Exact Distributions for Rank and Permutation Tests. 2010. R package version 0.8-17. http://CRAN.R-project.org/ package= exactRankTests.
28. Karamitopoulou E, Lugli A, Panayiotides I, et al. Systematic assessment of protein phenotypes characterizing high-grade tumour budding in mismatch repair-proficient colorectal cancer. Histopathology 2010;57:233-243.
29. Sonoo H, Kameyama M, Inatugi N, et al. Pedunculated polyp of early sigmoid colon cancer with invasive micropapillary carcinoma. Jpn J Clin Oncol 2009;39: 523-527.
30. Tot T. Cytokeratins 20 and 7 as biomarkers: usefulness in discriminating primary from metastatic adenocarci-noma. Eur J Cancer 2002;38:758-763. (Pubitemid 34280319)
31. Logani S, Oliva E, Arnell PM, et al. Use of novel immunohistochemical markers expressed in colonic adenocarcinoma to distinguish primary ovarian tumors from metastatic colorectal carcinoma. Mod Pathol 2005;18:19-25. (Pubitemid 40128090)
32. Colomer A, Erill N, Verdú M, et al. The lack of p53 nuclear immunostaining is not indicative of absence of TP53 gene mutations in colorectal adenocarcinomas. Appl Immunohistochem Mol Morphol 2003;11: 130-137. (Pubitemid 36749565)
33. Greenblatt MS, Bennett WP, Hollstein M, et al. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994;54:4855-4878. (Pubitemid 24289415)